A 76-year-old man presented with a cough. Chest CT revealed a 45-mm mass in the left upper lobe. Transbronchial tumor biopsies showed adenocarcinoma. CT and bone scintigraphy revealed lung, pleura, and bone metastases. He was diagnosed with left upper lobe adenocarcinoma cT2bN3M1c stage IVB. Genetic analysis of the primary tumor revealed positivity for epidermal growth factor receptor (EGFR) (L858R) and CTNNB1 mutations. He was treated with osimertinib (80 mg/day) as first-line therapy and achieved clinical improvement and a partial response. Six months later, the tumor increased in size, indicating progressive disease. Osimertinib was stopped, and second-line therapy with carboplatin (area under the curve 5) and pemetrexed (500â€‰mg/m2) was initiated. After